Royal Bank of Canada »

Akero Therapeutics shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2023-12-31 $706k 30k 23.23
2023-09-30 $812k 19k 43.48
2023-06-30 $228k 4.9k 47.00
2022-12-31 $531k 5.3k 100.00
2022-09-30 $88k 2.6k 33.91
2021-06-30 $99k 4.0k 24.86
2021-03-31 $96k 3.3k 29.52
2020-12-31 $70k 1.8k 38.46
2020-09-30 $34k 1.1k 31.16
2020-06-30 $27k 1.1k 24.75
2020-03-31 $23k 1.1k 20.41
2019-12-31 $17k 744 22.85
2019-09-30 $1.0k 44 22.73